{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:14:45Z","timestamp":1789820085848,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jtha.2024.05.027","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T11:31:45Z","timestamp":1718019105000},"page":"2900-2909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Examining variability in the diagnosis and management of people with bleeding disorders of unknown cause: communication from the ISTH SSC Subcommittee on von Willebrand Factor"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5172-0046","authenticated-orcid":false,"given":"Claire","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross I.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Analia","family":"Sanchez-Luceros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2999-4216","authenticated-orcid":false,"given":"Michelle","family":"Lavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.05.027_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/hae.12811","article-title":"Unclassified bleeding disorders: outcome of haemostatic challenges following tranexamic acid and\/or desmopressin","volume":"22","author":"Obaji","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.05.027_bib2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/hae.14174","article-title":"Bleeding of unknown cause and unclassified bleeding disorders; diagnosis, pathophysiology and management","volume":"26","author":"Thomas","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.05.027_bib3","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood.2020010038","article-title":"How I treat bleeding disorder of unknown cause","volume":"138","author":"Baker","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.027_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3324\/haematol.10816","article-title":"High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls","volume":"92","author":"Quiroga","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.05.027_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/hae.13422","article-title":"High proportion of patients with bleeding of unknown cause in persons with a mild-to-moderate bleeding tendency: results from the Vienna Bleeding Biobank (VIBB)","volume":"24","author":"Gebhart","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.05.027_bib6","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1111\/jth.15492","article-title":"Current practice and registration patterns among United Kingdom Haemophilia Centre Doctors\u2019 Organisation centers for patients with unclassified bleeding disorders","volume":"19","author":"Thomas","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.027_bib7","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1182\/bloodadvances.2020002452","article-title":"Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause","volume":"4","author":"Mehic","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.05.027_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12511","article-title":"Fibrinolysis and bleeding of unknown cause","volume":"5","author":"Mehic","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.027_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/ijlh.13155","article-title":"Investigation of patients with unclassified bleeding disorder and abnormal thrombin generation for physiological coagulation inhibitors reveals multiple abnormalities and a subset of patients with increased tissue factor pathway inhibitor activity","volume":"42","author":"MacDonald","year":"2020","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2024.05.027_bib10","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/jth.14529","article-title":"Thrombin-generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause","volume":"17","author":"Hofer","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.027_bib11","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/jth.15687","article-title":"Low COAT platelets are frequent in patients with bleeding disorders of unknown cause (BDUC) and can be enhanced by DDAVP","volume":"20","author":"Segot","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.027_bib12","first-page":"1734","article-title":"A\u00a0morphometric analysis of platelet dense granules of patients with unexplained bleeding: a new entity of delta-microgranular storage pool deficiency","volume":"9","author":"Gunning","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2024.05.027_bib13","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/bjh.18003","article-title":"Multiparameter platelet function analysis of bleeding patients with a prolonged platelet function analyser closure time","volume":"196","author":"Heubel-Moenen","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.05.027_bib14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J\u00a0Biomed Inform"},{"key":"10.1016\/j.jtha.2024.05.027_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J\u00a0Biomed Inform"},{"key":"10.1016\/j.jtha.2024.05.027_bib16","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jtha.2022.11.045","article-title":"Variability in International Society on Thrombosis and Haemostasis-Scientific and Standardization Committee endorsed Bleeding Assessment Tool (ISTH-BAT) score with normal aging in healthy females: contributory factors and clinical significance","volume":"21","author":"Doherty","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.027_bib17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/hae.12503","article-title":"Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project","volume":"20","author":"Elbatarny","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.05.027_bib18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/hae.12020","article-title":"Suspected collagen disorders in the bleeding disorder clinic: a case-control study","volume":"19","author":"Jackson","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.05.027_bib19","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1016\/j.rehab.2018.05.907","article-title":"Patients with bleeding of unknown cause and joint hypermobility: clinical assessment and genetic screening","volume":"61","author":"Sanchez-Raya","year":"2018","journal-title":"Ann Phys Rehabil Med"},{"key":"10.1016\/j.jtha.2024.05.027_bib20","doi-asserted-by":"crossref","first-page":"11332","DOI":"10.1182\/blood-2022-158706","article-title":"Iron deficiency anemia and von Willebrand disease in women with menorrhagia","volume":"140","author":"Campos-Cabrera","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.027_bib21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.05.027_bib22","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1111\/jth.15781","article-title":"Expert opinion on the use of platelet secretion assay for the diagnosis of inherited platelet function disorders: communication from the ISTH SSC Subcommittee on Platelet Physiology","volume":"20","author":"Mezzano","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.027_bib23","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/jth.12650","article-title":"Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey","volume":"12","author":"Gresele","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.027_bib24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jth.12792","article-title":"Subcommittee on Platelet Physiology of the International Society on Thrombosis and Hemostasis. Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH","volume":"13","author":"Gresele","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.027_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12546","article-title":"Tranexamic acid evidence and controversies: an illustrated review","volume":"5","author":"Relke","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.027_bib26","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1111\/jth.15871","article-title":"Outcomes and management of pregnancy in women with bleeding disorder of unknown cause","volume":"20","author":"Castle","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.027_bib27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/ijlh.13124","article-title":"Characterization of a large cohort of patients with unclassified bleeding disorder; clinical features, management of haemostatic challenges and use of global haemostatic assessment with proposed recommendations for diagnosis and treatment","volume":"42","author":"MacDonald","year":"2020","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2024.05.027_bib28","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1055\/s-0041-1726344","article-title":"Outcome of surgical interventions and deliveries in patients with bleeding of unknown cause: an observational study","volume":"121","author":"Veen","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.027_bib29","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jtha.2023.03.006","article-title":"Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding Biobank","volume":"21","author":"Mehic","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.027_bib30","doi-asserted-by":"crossref","first-page":"E285","DOI":"10.1002\/ajh.25928","article-title":"Efficacy and safety of half-dose desmopressin for bleeding prophylaxis in bleeding disorder patients undergoing predominantly low to moderate risk invasive procedures","volume":"95","author":"Furqan","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2024.05.027_bib31","article-title":"Bleeding disorder of unknown cause: a diagnosis of exclusion","author":"Mehic","year":"2024","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.jtha.2024.05.027_bib33","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/hae.14643","article-title":"Gynaecological management of women with inherited bleeding disorders. A UK Haemophilia Centres Doctors\u2019 Organisation Guideline","volume":"28","author":"Curry","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.05.027_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajog.2023.01.017","article-title":"The relationship between heavy menstrual bleeding, iron deficiency, and iron deficiency anemia","volume":"229","author":"Munro","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2024.05.027_bib36","first-page":"e193","article-title":"on behalf of the Royal College of Obstetricians and Gynaecologists. Management of inherited bleeding disorders in pregnancy","volume":"124","author":"Pavord","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.jtha.2024.05.027_bib37","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.jtha.2024.03.005","article-title":"Standardisation of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH","volume":"22","author":"Baker","year":"2024","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.027_bib38","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/hae.14810","article-title":"Reported prevalence of von Willebrand disease worldwide in relation to income classification","volume":"29","author":"Stonebraker","year":"2023","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.05.027_bib39","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/hae.14804","article-title":"von Willebrand disease: gaining a global perspective","volume":"29","author":"O'Sullivan","year":"2023","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.05.027_bib40","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3324\/haematol.2022.280816","article-title":"APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis","volume":"108","author":"Stritt","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.05.027_bib41","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1182\/blood-2014-10-604553","article-title":"Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutation","volume":"125","author":"Dargaud","year":"2015","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624003192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624003192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T20:46:29Z","timestamp":1759351589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624003192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1538783624003192"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.05.027","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining variability in the diagnosis and management of people with bleeding disorders of unknown cause: communication from the ISTH SSC Subcommittee on von Willebrand Factor","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}